HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Stages of Objective Memory Impairment Predict Alzheimer's Disease Neuropathology: Comparison with the Clinical Dementia Rating Scale-Sum of Boxes.

AbstractBACKGROUND:
The ultimate validation of a clinical marker for Alzheimer's disease (AD) is its association with AD neuropathology.
OBJECTIVE:
To examine how well the Stages of Objective Memory Impairment (SOMI) system predicts intermediate/high AD neuropathologic change and extent of neurofibrillary tangle (NFT) pathology defined by Braak stage, in comparison to the Clinical Dementia Rating (CDR) Scale sum of boxes (CDR-SB).
METHODS:
251 well-characterized participants from the Knight ADRC clinicopathologic series were classified into SOMI stage at their last assessment prior to death using the free recall and total recall scores from the picture version of the Free and Cued Selective Reminding Test with Immediate Recall (pFCSRT + IR). Logistic regression models assessed the predictive validity of SOMI and CDR-SB for intermediate/high AD neuropathologic change. Receiver operating characteristics (ROC) analysis evaluated the discriminative validity of SOMI and CDR-SB for AD pathology. Ordinal logistic regression was used to predict Braak stage using SOMI and CDR-SB in separate and joint models.
RESULTS:
The diagnostic accuracy of SOMI for AD diagnosis was similar to that of the CDR-SB (AUC: 85%versus 83%). In separate models, both SOMI and CDR-SB predicted Braak stage. In a joint model SOMI remained a significant predictor of Braak stage but CDR-SB did not.
CONCLUSION:
SOMI provides a neuropathologically validated staging system for episodic memory impairment in the AD continuum and should be useful in predicting tau positivity based on its association with Braak stage.
AuthorsEllen Grober, Qi Qi, Lynn Kuo, Jason Hassenstab, Richard J Perrin, Richard B Lipton
JournalJournal of Alzheimer's disease : JAD (J Alzheimers Dis) Vol. 80 Issue 1 Pg. 185-195 ( 2021) ISSN: 1875-8908 [Electronic] Netherlands
PMID33492286 (Publication Type: Comparative Study, Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
Chemical References
  • MAPT protein, human
  • tau Proteins
Topics
  • Aged
  • Aged, 80 and over
  • Alzheimer Disease (pathology, psychology)
  • Disease Progression
  • Educational Status
  • Female
  • Humans
  • Male
  • Memory Disorders (psychology)
  • Memory, Episodic
  • Mental Recall
  • Mental Status and Dementia Tests
  • Neurofibrillary Tangles (pathology)
  • Neuropsychological Tests
  • Predictive Value of Tests
  • ROC Curve
  • Reproducibility of Results
  • Severity of Illness Index
  • tau Proteins (genetics)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: